Why Im Not Arbing The Fresenius Akorn Deal | Latest News RSS feed

Why Im Not Arbing The Fresenius Akorn Deal - Latest News

Why I'm Not Arbing The Fresenius / Akorn Deal

I am not interested in risk-arbing this deal at the current risk/reward profile (6.25% in 1 year). The deal continues to make sense from a strategic perspective for Fresenius, but I think Akorn has si... read more

Corruption Currents: Trump Asserts ‘Absolute Immunity’ in Emoluments Lawsuit

(AM ... if she is not indicted on charges of misusing government funds. (Haaretz) Court documents made public this week show Germany-based healthcare company Fresenius Medical Care & Co. said it found ... read more

Fresenius walks away from Akorn deal

Akorn shares were down 32 percent this morning. Investors had become increasingly wary of the deal since Fresenius announced it a year ago. Competition was eroding Akorn's profit and revenue expectati... read more

Looking for another news?

Could Data Breaches Break Up the Akorn Aquisition?

This isn’t the first time that Akorn has faced concerns regarding its security, but this could be the costliest. Essentially, Fresenius is conducting an independent investigation into “alleged breache... read more

Akorn V. Fresenius - Post Trial Thoughts

Akorn ... end of Fresenius. Particularly damning were emails between Fresenius CEO Sturm and his deputies suggesting he wanted out of this deal after AKRX’s poor earnings results. Nonetheless, Judge L... read more

Here's Why Akorn, Inc. Stock Is Getting Thrashed Today

Last April, Fresenius agreed to acquire Akorn for $34 per share, which was a steep premium to the stock's price during the weeks leading up to the announcement. As is usually the case when deals appea... read more

Why Diana Shipping, Akorn, and Granite Construction Jumped Today

But if JPMorgan is right, then a greater level of confidence in the shipping industry could lead to further gains not just for ... Already, Fresenius has made some strategic purchases within Europe, b... read more

Akorn CEO says Fresenius is using smear campaign to nix $4.3B deal

(Bloomberg) — Akorn Inc.'s top executive complained Fresenius SE officials are unfairly smearing his firm's reputation as the German company tries to pull out of $4.3 billion deal to to buy the ... wi... read more

McLane : Why Sunoco Is ‘Economic Cycle-Proof’

Why Sunoco Is 'Economic Cycle-Proof' 02/27/2016 - HOUSTON -- Sunoco LP ... while Sunoco LP executives 'are working on some smaller deals,' there were no spoiler alerts from Owens. 'I am optimistic tha... read more

Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 crore

The recent Pfizer-Hospira deal, as per industry ... Infact, in 2012, Akorn acquired certain injectable assets of Indian CMO Kilitch Drugs. Analysts add, among the buyers, the maximum strategic value w... read more

The Morning Ledger: Volkswagen Prepares First U.S. Bond Sale After Emissions Scandal

Akorn pledges to fight Fresenius decision to end deal. Fresenius SE on Sunday said it is terminating ... Compensation details were not immediately available. The Morning Ledger from CFO Journal cues u... read more

How Does American Airlines Fly 200 Million People a Year?

American could not approach its current level of success if not for the ... Despite its new name, it still had old problems to deal with, specifically a loss of $1.8 billion that put the airline on Fo... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us